News

SAN CARLOS, Calif., June 2, 2021 /PRNewswire/ — Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced the closing of a Series B financing of $10 million. SHD (Scientific Health Development) led the round, with additional investment from GP&G (Green Park & Golf) and other syndicate members. The funds will be used […]

Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases in both upper and lower extremities Koya Medical strengthens leadership team with appointments of three industry veterans to support commercial expansion OAKLAND, Calif., May 26, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and

Pilot CRS Study to Evaluate Performance of Novel Aortix device in Australia and the U.S. HOUSTON, TX – MAY 25, 2021 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the company’s pilot trial to evaluate the

OAKLAND, Calif., May 20, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, will present at the Oppenheimer MedTech, Tools & Diagnostics Summit on Wednesday, May 26, 2021. Koya Founder, CEO and President Andy Doraiswamy, Ph.D., will provide an overview of Koya’s recent business milestones and developments

MODERN AESTHETICS® NEWS ? If you haven’t heard of Eirion Therapeutics yet, you will. That’s a promise. Headquartered in Woburn, MA, the aesthetic dermatology company boasts a disruptive pipeline focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair graying and just scored some major financing. Jon Edelson, MD, Eirion’s Chairman, CEO, and

WOBURN, Mass, March 9, 2021 /PRNewswire/ Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with Shanghai Haohai Biological Technology Ltd. (“Haohai”) that will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eirion’s products for

Empirical Spine, Inc., a company developing advanced solutions for the surgical treatment of spinal disorders, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) for its LimiFlex™ Paraspinous Tension Band. In doing so, the FDA has determined that LimiFlex™ holds the potential to offer significant advantages over existing

OAKLAND, Calif., March 4, 2021 — Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous disorders, today announced the appointment of Ali Bauerlein to its Board of Directors. Ms. Bauerlein brings more than 20 years of experience in the medical technology space as the CFO and co-founder of Inogen, Inc.

Empirical Spine, Inc., maker of the LimiFlex™ Paraspinous Tension Band, today announced initiation of the PMA process for FDA review and approval of the use of the LimiFlex with a decompression for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis. The Pivotal Trial supporting the PMA compares outcomes of patients who receive either LimiFlex

By Katie Kindelan Kristyn Watkins got her first menstrual cycle when she was 10 years old and then suffered from what she describes as debilitating, heavy periods for nearly the next three decades. “As a young child, I thought it was normal to have an extremely heavy flow and it continued my entire life,” Watkins, 37, told